Purposeful/versatile global executive; Building impactful business venture is the vision, connecting strategy with execution and skilled collaboration is the approach, having fun doing so is the spirit
We cannot be more excited to announce that we, together with our collaborators in UK, have received MHRA Approval to Commence Phase IIb Stroke Trial. As you recall, late last year we received a Qualified Person’s Declaration Equivalence to UK / EU GMP for Investigational Medicinal Products Manufactured outside of EU (in Third Countries). After which we submitted and received this regulatory approval. It has been a long and rigorous preparation for this trial. We are extremely proud and grateful for this approval, and look forward to commencing the trial to tackle the unmet medical needs for many patients and a costly burden to the healthcare system. Link to this press release: https://lnkd.in/gFPfgBUw